MARCQ-EN-BAROEUL, FR — Lesaffre, an independent global player in fermentation and microorganisms, announced a majority stake acquisition in Biorigin, a business unit of multinational yeast derivative producer Zilor.
The acquisition enhances the supply of yeast derivatives for savory ingredients and improves production processes, logistics and services for Lesaffre’s global customer base.
With 70% of its total corporate capital, Lesaffre will become the controlling shareholder of Biorigin, while Zilor will remain a shareholder with 30%. The deal includes Biorigin’s production unit in Quata/Sao Paulo.
“This acquisition of a majority stake in Biorigin represents an exciting new chapter for Lesaffre,” said Brice-Audren Riche, CEO of Lesaffre. “It will offer development opportunities to meet the growing needs of the human food and nutrition industries, as society currently demands savory ingredients from natural sources.”